{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:59:11Z","timestamp":1791903551209,"version":"4.3.4"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>An intravenous drug called sugammadex is used to counteract the adverse reactions of the relaxation medications rocuronium and vecuronium, which are given during operations to provide full anesthesia. The principal objective of the presented study is developing and validating a complete, innovative, fast, isocratic, and green shelf life liquid chromatography methodology, Sugammadex sodium levels in injectable therapies can now be measured. A number of tests were performed on sugammadex sodium in accordance with ICH guidelines. Sugammadex sodium and its related degradants were effectively separated via isocratic separation. At ambient conditions, the Zorbax SB ODS stationary phase was used to quantify and validate the drug substance. The isocratic mobile phase runs at a flow rate of 1.0\u2009mL\/min. It includes the eluting phase that comprises of 7\u2009mL\/L aqueous solution of triethylamine adjusted at pH\u20093.0 with phosphoric acid: ethanol (750:250) (V:V). The positive environmental impacts of the LC technique are demonstrated by the combined AES grade of 87, CACI rating of 78, AGSA rating of 75, MoGAPI rating of 80, BAGI rating of 82.5, and final whiteness rating of 96.7.<\/jats:p>","DOI":"10.1002\/bmc.70267","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:07:57Z","timestamp":1764317277000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimization and Validation of a Green Shelf Life HPLC Technique for Testing Sugammadex Sodium in Raw Material and Parenteral Medications"],"prefix":"10.1002","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9000-3777","authenticated-orcid":false,"given":"Ahmed\u00a0Sobhy","family":"Darwish","sequence":"first","affiliation":[{"name":"Faculty of Science Zagazig University  Zagazig Egypt"},{"name":"Egyptian International Pharmaceutical Industries (EIPICO) Company  Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-3413","authenticated-orcid":false,"given":"Sherief\u00a0M.","family":"Abdel\u2010Raheem","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Veterinary Medicine King Faisal University  Al\u2010Ahsa Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed\u00a0M.\u00a0A.","family":"Meligy","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Central lab, College of Veterinary Medicine King Faisal University  Al\u2010Ahsa Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad\u00a0Ibrahim","family":"Al\u2010sultan","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Veterinary Medicine King Faisal University  Al\u2010Ahsa Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-5147","authenticated-orcid":false,"given":"Mahmoud","family":"Kandeel","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Veterinary Medicine King Faisal University  Al\u2010Ahsa Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wageh\u00a0Sobhy","family":"Darwish","sequence":"additional","affiliation":[{"name":"Food Hygiene, Safety and Technology Department, Faculty of Veterinary Medicine Zagazig University  Zagazig Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.21608\/ejvs.2023.234808.1667"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2025.100407"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198506980.001.0001"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10337\u2010022\u201004146\u2010y"},{"key":"e_1_2_11_6_1","volume-title":"Medicines and Healthcare Products Regulatory Agency, the Stationery Office on Behalf of the MHRA","author":"British Pharmacopoeia","year":"2025"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.21608\/bfszu.2025.357849.1475"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2025.114716"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70152"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2011.03.050"},{"key":"e_1_2_11_11_1","unstructured":"DRUGBANK online website. accessed September 27 2025https:\/\/go.drugbank.com\/drugs\/DB06206."},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoacint\/qsaa006"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2013.04.010"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.21608\/bfszu.2025.343593.1456"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102739"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2025.100538"},{"key":"e_1_2_11_17_1","volume-title":"Harmonized Tripartite Guideline\u2010Validation of Analytical Procedures: Text and Methodology Q2 (R2)","author":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH","year":"2023"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.106685"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sampre.2023.100068"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2025.100565"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102338"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3GC02347H"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2025.102051"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sampre.2025.100164"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/analytica6030025"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/analytica5030030"},{"key":"e_1_2_11_27_1","unstructured":"Merck. Accessed September 27 2025https:\/\/www.sigmaaldrich.com\/EG\/en\/product\/sigma\/sml3224?srsltid=AfmBOorX\u20102lbAK1smTMwC5kHBO\u2010ILUJd6YBeJGbo\u2010fxf3ujn2B9xWtT2."},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116223"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3AY00452J"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v10i1.3842"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2014.09.050"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/jasms.4c00243"},{"key":"e_1_2_11_33_1","doi-asserted-by":"crossref","unstructured":"The United States Pharmacopeia United Stated Pharmacopeial Convention North Bethesda Maryland United States USPNF 2025 online Validation of Compendial Procedures.https:\/\/doi.org\/10.31003\/USPNF_M99945_04_01.","DOI":"10.31003\/USPNF_M99945_04_01"},{"key":"e_1_2_11_34_1","unstructured":"US Food and Drug Administration Office of Regulatory Affairs Quality Accessed September 20 2025.https:\/\/www.fda.gov\/media\/73920\/download."},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4AY01185F"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.08.027"},{"key":"e_1_2_11_37_1","unstructured":"Wikepedia The Free Encyclopedia. Accessed September 27 2025https:\/\/en.wikipedia.org\/wiki\/Sugammadex."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10098\u2010021\u201002188\u20108"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114072"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.70267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:49:37Z","timestamp":1766072977000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.70267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1002\/bmc.70267"],"URL":"https:\/\/doi.org\/10.1002\/bmc.70267","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"value":"0269-3879","type":"print"},{"value":"1099-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"2025-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70267"}}